Trials / Completed
CompletedNCT05625984
Study With Fascigel
Multi-centre, Open-label, First-in-man Study With Fascigel Used in Adult Patients Suffered From Back Pain
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 55 (actual)
- Sponsor
- Contipro Pharma a.s. · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The product is a Class III Medical Device. Structure is made by 1% sodium hyaluronate polysaccharide in normal saline solution. The device intended use is to help treat back pain by lubricating fascia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Fascigel | The product is a Class III Medical Device. Structure is made by 1% sodium hyaluronate polysaccharide in normal saline solution. |
Timeline
- Start date
- 2022-10-24
- Primary completion
- 2023-11-13
- Completion
- 2023-11-13
- First posted
- 2022-11-23
- Last updated
- 2024-02-07
Locations
3 sites across 1 country: Czechia
Source: ClinicalTrials.gov record NCT05625984. Inclusion in this directory is not an endorsement.